Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.
Personalis has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.
Personalis's investors include Lightspeed Venture Partners, Tempus, Abingworth, Merck, Stanford University.
Personalis is headquartered in Menlo Park, United States.
Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.
Personalis is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Personalis — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/personalis. Accessed September 30, 2026.
VCBacked. (2024). Personalis — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/personalis
{{cite web |title=Personalis — Funding & Investors |url=https://www.vcbacked.co/company/personalis |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated